Viagra and Pharma : A Risky Investment ?

The storied success of copyright’s flagship drug has undeniably influenced the healthcare landscape. However, investing in companies heavily dependent on biosimilars and the declining patent protection surrounding this flagship medication presents a significant degree of peril . While major pharm

read more